Researchers at Colorado State University have identified an alternate method to study changes during the DNA replication ...

In the wake of Pfizer’s voluntary market withdrawal of the popular sickle cell disease therapy, BioSpace looks at five investigational drugs currently making their way through the pipeline.

Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.

As we commemorate the recent one-year anniversary of renowned health journalist who was also a friend, Elizabeth Merab, we ...

Indian company Akums Drugs and Pharmaceuticals has introduced Hydroxyurea oral suspension, the country’s first room temperature-stable drug for treating sickle cell disease, according to a ...

The work focuses on hydroxyurea, a chemotherapy drug used in clinical settings to treat cancer, which is also frequently used in research settings to arrest cells in their development cycle for study.

Researchers at Colorado State University have developed a novel method using genetically modified yeast to study DNA ...

Investigators added more data to an analysis first published in 2020 and got the same result: ruxolitinib beats other ...

Researchers at Colorado State University discovered an alternative way for studying alterations during the DNA replication process in lab settings using genetically modified yeast. The novel ...

ICMR partners with Zydus Lifesciences for Desidustat phase-2 trials in sickle cell disease patients, aiming for innovative ...